GLP-1 analog comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-01-04. Where a claim depends on a specific study, the study is described rather than over-claimed.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | Peptide backbone with a C18 fatty diacid side chain |
| Molecular weight | Approximately 4113 Da | Consistent with a 31-residue peptide plus linker |
| Appearance | White to off-white powder | Lyophilized solid; hygroscopic if left open |
| Solubility class | Sparingly soluble to soluble in water | Varies with pH and ionic strength |
| Typical analytical method | Reversed-phase HPLC with UV detection | Often paired with mass spectrometry for identity |
Routine characterisation of the peptide relies on reversed-phase high-performance liquid chromatography, often paired with ultraviolet detection near 214 nanometres. Related substances such as deamidated, oxidised, and truncated sequences elute at characteristic positions and are quantified by area percentage. Electrospray ionisation mass spectrometry confirms the molecular mass and can resolve some closely related variants. Peptide mapping after enzymatic digestion provides sequence-level verification and is useful when a full identity profile is required. Method parameters such as column chemistry, gradient, and mobile-phase pH influence the separation and must be reported alongside results.
Material described as research-grade is not necessarily manufactured to pharmaceutical standards, and purity figures depend on the method used to obtain them. A certificate of analysis states the measured purity, the analytical technique, and the batch identifier, but the underlying data are not always included. Independent testing by a second laboratory is a common way to confirm identity and purity. Uncertainties remain about how storage history affects long-term stability, and about how well results from one laboratory transfer to another. Documentation of handling conditions supports comparison between batches.
As a peptide, semaglutide is sensitive to conditions that break amide bonds or modify side chains. Deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation are the main degradation routes described in published stability work. Rate depends strongly on pH, buffer species, ionic strength, temperature and exposure to light. Formulators therefore choose a defined solution pH and often add excipients such as phosphate buffer, propylene glycol and phenol, each of which plays a separate role in pH control, tonicity or preservation.
Storage guidance for the finished injectable product distinguishes the unused state from the in-use state. Before first use, pens are kept refrigerated between 2 and 8 degrees Celsius, protected from light, and never frozen, since freezing can disrupt the peptide or the device. After first use, label instructions in several markets permit storage at room temperature up to about 30 degrees Celsius for a limited number of days. Solid research-grade material is normally held at or below minus 20 degrees Celsius, often with desiccant, and allowed to equilibrate before opening.
On 17 May 2002, Norris injected patient Vera Wilby with an overdose of the painkiller morphine to make her drowsy (as recorded in the hospital notes and later admitted by Norris), despite the fact that she was in no pain and needed no morphine. He then administered insulin before going off shift, for no apparent medical reason. Ninety minutes after he went off shift, Wilby was found to be semi-conscious and suffering from a sudden hypoglycaemic attack, but she survived. Wilby had dementia and had been seen as a "difficult" patient by Norris. On 12 June, another patient, Doris Ludlam, was admitted to Norris's ward with a broken hip. On 25 June, she was also given an unnecessary injection of morphine (as recorded in the hospital notes and later admitted by Norris) followed by an overdose of insulin, and Norris then again went off shift. She was discovered in a coma 40 minutes after he went off shift. 88-year-old Bridget Bourke, who had been admitted to the ward on 16 June also with a broken hip, was then discovered at 3:10 a.m. on 21 July (by Norris) suffering from a hypoglycaemic attack; she died the next day. Norris was then transferred to St James's University Hospital, and on 10 October 2002, 79-year-old Irene Crookes was admitted to Norris's new ward with a broken hip. Despite Norris recording that her condition was improving, he supposedly found her "totally unresponsive" just before 6 a.m. on 19 October, having suffered a hypoglycaemic attack. She died the next day.
=== Contestants === 1st - Sinai Vespie, Pastry Chef from Mishawaka, Indiana 2nd - Renee Loranger, Pastry Chef from Waveland, Mississippi 3rd - Aaron Clouse, Pastry Chef from Columbus, Ohio 4th - Michelle Lee, Sous Chef from Monterey, California 5th - Michael Gaddy, Pastry Chef from Dade City, Florida 6th - Brian Bosch, Event Designer from Santa Ana, California 7th - Tamara Brown, from Los Angeles, California 8th - Holly Braddock, Pastry Chef from Myrtle Beach, South Carolina 9th - Nerwan Khalife, Pastry Chef from Bronx, New York 10th - Edward Cunningham, Railroad Heavy Equipment Operator from Chicago, Illinois
=== Activism === During the popularity of Public Enemy, Ice-T was closely associated with the band and his recordings of the time showed a similar political viewpoint. He was referred to as "The Soldier of the Highest Degree" in the booklet for Fear of a Black Planet and mentioned on the track "Reggie Jax". Ice-T's track This One's For Me included a defense of Professor Griff after the antisemitism controversy and attacked other rappers for not speaking out in his defense. At the Hollywood Walk of Fame ceremony for Ice-T, Chuck D appeared on stage alongside his longtime friend. Ice-T also collaborated with fellow vocalist and anti-censorship campaigner Jello Biafra on his album The Iceberg/Freedom of Speech... Just Watch What You Say!. He and Biafra appeared on The Oprah Winfrey Show in 1990 to debate Tipper Gore on censorship in music. After the controversy of the Body Count song Cop Killer, Ice-T became an icon for free-speech campaigners, which led to a doubling in album sales. The song was condemned by both George H. W. Bush and Dan Quayle during the 1992 United States presidential election. When he decided to withdraw the song from his album, he replaced it with a metal version of his rap Freedom of Speech. A 2004 Guardian article wrote, "He's toured universities lecturing on first amendment rights and civil liberties and is vocal about the billions wasted on the Iraq war. He insists, however, he'd never get involved in politics." The last track of OG Original Gangster condemned both the Gulf War and mass incarceration.
=== Spring 2003 === A US veteran sergeant reports witnessing torture of journalists and writers all over Iraq. Kurdistan region was not an exception. Writers without Borders embarrassed the Iraqi government quite frequently in reports covering minority, women and marginalised Iraqis from all over the country but with much focus on Baghdad, Karkuk, Salahedin and Mosul. Honorably discharged US veteran, Sergeant Frank "Greg" Ford reports that he witnessed war crimes in Samarra, Iraq. According to Ford, several members of his own unit, the 205th Military Intelligence Brigade participated in the torture of Iraqi detainees as young as 14. Ather Karen al-Mowafakia died in Basra, while in British custody. Details about the investigation are not known. Gary Bartlam, a British soldier of the 7th Armoured Brigade, was arrested after submitting film to a photo developers shop in Tamworth, England while on leave. The photographs depict a gagged Iraqi POW suspended hanging by rope from a fork lift, and other pictures seem to show prisoners being forced to perform sexual acts. Bartlam and two other soldiers were convicted at court martial of abuse - a fourth soldier was cleared. British Lieutenant Colonel Tim Collins was alleged by US Army Major Re Biastre to have been responsible for mistreatment of Iraqi civilians and prisoners of war. Lieutenant Colonel Collins was later cleared of any wrongdoing by an MOD investigation.
=== Mechanism of action === Carbamazepine is a sodium channel blocker. It binds preferentially to voltage-gated sodium channels in their inactive conformation, which prevents repetitive and sustained firing of an action potential. Carbamazepine has effects on serotonin systems but the relevance to its antiseizure effects is uncertain. There is evidence that it is a serotonin releasing agent and possibly even a serotonin reuptake inhibitor. It has been suggested that carbamazepine can also block voltage-gated calcium channels, which will reduce neurotransmitter release.
Sources: en.wikipedia.org
artificial gene synthesis A set of laboratory methods used in the de novo synthesis of a gene (or any other nucleic acid sequence) from free nucleotides, i.e. without relying on an existing template strand.
=== Signaling === D-Serine, synthesized in neurons by serine racemase from L-serine (its enantiomer), serves as a neuromodulator by coactivating NMDA receptors, making them able to open if they then also bind glutamate. D-serine is a potent agonist at the glycine site (NR1) of canonical diheteromeric NMDA receptors. For the receptor to open, glutamate and either glycine or D-serine must bind to it; in addition a pore blocker must not be bound (e.g. Mg2+ or Zn2+). Some research has shown that D-serine is a more potent agonist at the NMDAR glycine site than glycine itself. However, D-serine has been shown to work as an antagonist/inverse co-agonist of t-NMDA receptors through the glycine binding site on the GluN3 subunit.
In February 1983 he fell over in the melée (he said at the time that he was pushed) when CND protestors surrounded a meeting of Newbury Conservatives, a propaganda gift, and on Good Friday 1983 he was filmed in West Berlin looking over the wall to the communist east, distracting attention from CND's linking of arms round Greenham Common that day. With a general election looming, Heseltine was keen to associate Labour with CND, and CND with communists and the Soviet Union (ignoring earlier comments by Party Chairman Cecil Parkinson that this was "manifest nonsense" – the media did not pick up on this). He made such a claim in a speech at Exeter in April 1983, and distributed to Tory candidates information about the background of leading members of CND. This had been assembled by Ray Whitney MP, but some of it was suspected of having come from intelligence sources. MI5 agent Cathy Massiter later wrote, in 1985 in The Observer, that from 1981 onwards and especially from 1983 she had been asked to pass on to DS19 (the propaganda unit at the Ministry of Defence) information obtained by wiretaps and by an MI5 mole in CID. MI5 bosses refused to pass on classified material about security matters but agreed to pass on information about the political links of CND members. Even this was in breach of the 1952 Directive from Home Secretary David Maxwell-Fyfe that the security services not provide information for party political purposes.
The comparatively low molecular mass leads to a better permeability in tissues, and to a short plasma half-life since they are eliminated renally. Unlike whole antibodies, they do not show complement system triggered cytotoxicity because they lack an Fc region. Camelid and fish derived sdAbs are able to bind to hidden antigens that are not accessible to whole antibodies, for example to the active sites of enzymes. This property has been shown to result from their extended CDR3 loop, which is able to penetrate such buried sites.
Sources: en.wikipedia.org
He grew up speaking French and German, and studied English on a three-week course in Cambridge, learning Italian, and Spanish to help his career. He also has a working knowledge of Japanese. On 13 October 2020, Wenger's second book, My Life in Red & White: My Autobiography, was published by W&N, translated from French.
== Pace-of-play initiatives == As a part of pace-of-play initiatives implemented in 2015, 20-second pitch clocks entered use at Double-A stadiums in 2015. In 2018, the time was shortened to 15 seconds when no runners are on base. Other significant changes implemented in 2018 included beginning extra innings with a runner on second base and limiting teams to eight mound visits during a nine-inning game. In 2019, the number of mound visits was reduced to seven, and pitchers were required to face a minimum of three consecutive batters, unless the side is retired or the pitcher is injured and unable to continue.
The anionic component of the salt has a certain significance in the manifestation of both general toxic and embryotoxic and teratogenic effects of lithium salts. For example, lithium oxybutyrate is characterized by a more pronounced general toxic effect at almost all times of administration and embryotoxic effect when administered during the period of organogenesis. Lithium carbonate has a more pronounced effect when administered at the early stages of embryogenesis.
Sources: en.wikipedia.org
It is given either as a once-weekly subcutaneous injection or as an oral tablet taken once daily. The two forms use different absorption strategies, so they are not interchangeable on a milligram-for-milligram basis.
Structural modifications, including a fatty acid side chain and non-natural amino acid substitutions, slow enzymatic breakdown and promote albumin binding. These changes support once-weekly dosing rather than twice-daily administration.
The pathways involving insulin, glucagon, gastric emptying, and appetite signaling are well described. How much each pathway contributes to weight reduction in a given person is not fully established.
Native GLP-1 is degraded within minutes by circulating enzymes. The synthetic version carries substitutions at positions that block enzymatic cleavage, plus a fatty acid side chain that promotes albumin binding. These two changes together extend circulation time from minutes to roughly a week.